HCA Holdings Aktie 11321027 / US40412C1018
303.42
USD
5.99
USD
2.01%
19:30:20
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
HCA Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | HCA Holdings Inc. | 0.89 | 2.40 | USD |
| 2022 | HCA Holdings Inc. | 0.93 | 2.24 | USD |
| 2021 | HCA Holdings Inc. | 0.75 | 1.92 | USD |
| 2020 | HCA Holdings Inc. | 0.26 | 0.43 | USD |
| 2019 | HCA Holdings Inc. | 1.08 | 1.60 | USD |
| 2018 | HCA Holdings Inc. | 1.12 | 1.40 | USD |
| 2017 | HCA Holdings Inc. | 0.00 | 0.00 | USD |
| 2016 | HCA Holdings Inc. | 0.00 | 0.00 | USD |
| 2015 | HCA Holdings Inc. | 0.00 | 0.00 | USD |
| 2014 | HCA Holdings Inc. | 0.00 | 0.00 | USD |
Gewinn je Aktie- HCA Holdings
| 19.0 23 | 19.2 22 | 21.2 21 | 10.9 20 | 10.1 19 | 10.7 18 | 6.0 17 |
Umsatz je Aktie- HCA Holdings
| 235 23 | 204 22 | 179 21 | 150 20 | 147 19 | 131 18 | 117 17 |
KGV- HCA Holdings
| 14.3 23 | 12.5 22 | 12.1 21 | 15.1 20 | 14.7 19 | 11.7 18 | 14.8 17 |
HCA Holdings Inc.: Die Aktie (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 18.97 | 19.15 | 21.16 | 10.93 | 10.07 | 10.66 | 5.95 |
| Gewinn je Aktie unverwässert | 19.24 | 19.44 | 21.51 | 11.10 | 10.27 | 10.90 | 6.12 |
| Gewinn je Aktie verwässert | 18.96 | 19.15 | 21.16 | 10.93 | 10.07 | 10.66 | 5.95 |
| Dividende pro Aktie | 2.40 | 2.24 | 1.92 | 0.43 | 1.60 | 1.40 | 0.00 |
| Gesamtdividendenausschüttung in Mio. | 661.00 | 653.00 | 624.00 | 153.00 | 550.00 | 487.00 | 0.00 |
HCA Holdings Inc.: Unternehmenskennzahlen (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 235.04 | 204.41 | 178.71 | 149.98 | 147.42 | 131.37 | 117.17 |
| KGV (Jahresendkurs, EPS unverwässert) | 14.27 | 12.53 | 12.14 | 15.05 | 14.69 | 11.68 | 14.75 |
| KGV (Jahresendkurs, EPS verwässert) | 14.27 | 12.53 | 12.14 | 15.05 | 14.69 | 11.68 | 14.75 |
| KGV (Jahresendkurs) | 14.27 | 12.53 | 12.14 | 15.05 | 14.69 | 11.68 | 14.75 |
| Dividendenrendite Jahresende in % | 0.89 | 0.93 | 0.75 | 0.26 | 1.08 | 1.12 | 0.00 |
| Eigenkapitalquote in % | 1.89 | -0.14 | 2.93 | 6.09 | -1.25 | -7.44 | -13.65 |
| Fremdkapitalquote in % | 98.11 | 100.14 | 97.07 | 93.91 | 101.25 | 107.44 | 113.65 |
HCA Holdings Inc.: GuV (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 64’968.00 | 60’233.00 | 58’752.00 | 51’533.00 | 51’336.00 | 46’677.00 | 43’614.00 |
| Umsatzveränderung in % | 7.86 | 2.52 | 14.01 | 0.38 | 9.98 | 7.02 | 5.12 |
| Bruttoergebnis vom Umsatz | 9’627.00 | 9’053.00 | 9’678.00 | 7’262.00 | 7’715.00 | 7’040.00 | 6’523.00 |
| Bruttoergebnisveränderung in % | 6.34 | -6.46 | 33.27 | -5.87 | 9.59 | 7.93 | -1.41 |
| Operatives Ergebnis | 9’627.00 | 9’053.00 | 9’678.00 | 7’262.00 | 7’218.00 | 6’593.00 | 6’057.00 |
| Veränderung Operatives Ergebnis in % | 6.34 | -6.46 | 33.27 | 0.61 | 9.48 | 8.85 | -2.09 |
| Ergebnis vor Steuern | 7’706.00 | 8’580.00 | 9’833.00 | 5’430.00 | 5’244.00 | 5’335.00 | 4’381.00 |
| Veränderung Ergebnis vor Steuern in % | -10.19 | -12.74 | 81.09 | 3.55 | -1.71 | 21.78 | -8.92 |
| Ergebnis nach Steuer | 5’242.00 | 5’643.00 | 6’956.00 | 3’754.00 | 3’505.00 | 3’787.00 | 2’216.00 |
| Veränderung Ergebnis nach Steuer in % | -7.11 | -18.88 | 85.30 | 7.10 | -7.45 | 70.89 | -23.32 |
HCA Holdings Inc.: Bilanz (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 55’151 | 52’511 | 49’253 | 44’598 | 45’623 | 42’125 | 41’588 |
| Langzeit Gesamtverbindlichk. pro Aktie | 160.04 | 153.61 | 129.87 | 105.75 | 111.88 | 100.78 | 101.20 |
| Eigenkapital | 1’060 | -73 | 1’489 | 2’892 | -565 | -2’918 | -4’995 |
| Veränderung Eigenkapital in % | 35.89 | -196.57 | -263.11 | - | 43.27 | 27.27 | 6.79 |
| Bilanzsumme | 56’211 | 52’438 | 50’742 | 47’490 | 45’058 | 39’207 | 36’593 |
| Veränderung Bilanzsumme in % | 7.20 | 3.34 | 6.85 | 5.40 | 14.92 | 7.14 | 8.40 |
HCA Holdings Inc.: Sonstige Angaben (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 19.24 | 19.44 | 21.51 | 11.10 | 10.27 | 10.90 | 6.12 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -0.99 | -9.66 | 93.87 | 8.03 | -5.80 | 78.28 | -18.82 |
| Gewinn je Aktie (verwässert) | 18.96 | 19.15 | 21.16 | 10.93 | 10.07 | 10.66 | 5.95 |
| Veränderung Gewinn je Aktie (verwässert) in % | -0.97 | -9.49 | 93.67 | 8.54 | -5.57 | 79.03 | -18.45 |
| Anzahl Mitarbeiter | 310’000 | 294’000 | 284’000 | 275’000 | 280’000 | 262’000 | 253’000 |
| Veränderung Anzahl Mitarbeiter in % | 5.44 | 3.52 | 3.27 | -1.79 | 6.87 | 3.56 | 4.98 |
HCA Holdings Inc. Termine
| Unternehmen | Event | Datum |
|---|---|---|
| HCA Holdings Inc. | Quartalszahlen | 04.02.2025 |
| HCA Holdings Inc. | Quartalszahlen | 18.04.2025 |
| HCA Holdings Inc. | Quartalszahlen | 23.07.2025 |
| HCA Holdings Inc. | Quartalszahlen | 04.11.2025 |
HCA Holdings Inc. vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 25.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 23.07.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 26.04.2024 |
| Hauptversammlung | Annual General Meeting | 25.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 30.01.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 24.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 27.07.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 21.04.2023 |
| Hauptversammlung | Annual General Meeting | 19.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 27.01.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 21.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 22.07.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 22.04.2022 |
| Hauptversammlung | Annual General Meeting | 21.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 27.01.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 71.46 |
| Hercules Holding II | 27.21 |
| The Vanguard Group, Inc. | 6.68 |
| Vanguard Group, Inc. (Subfiler) | 5.99 |
| Sanders Capital LLC | 4.56 |
| Wellington Management Co. LLP | 4.02 |
| State Street Corp. | 3.28 |
| Wellington Management Co. LLP (Wellington Breakout) | 2.53 |
| Vanguard Total Stock Market ETF | 2.25 |
| Vanguard 500 Index Fund | 1.94 |
| BlackRock Fund Advisors | 1.77 |
| First Eagle Investment Management LLC | 1.77 |
| BlackRock Institutional Trust Co. NA | 1.74 |
| Geode Capital Management LLC | 1.51 |
| First Eagle Global Fund | 1.23 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 253’000 | 262’000 | 280’000 | 275’000 | 284’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.17 | 0.18 | 0.18 | 0.19 | 0.21 |
Bilanz (in Mio. USD) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 9’977 | 10’213 | 11’196 | 12’333 | 13’542 |
| Summe Anlagevermögen | 26’616 | 28’994 | 33’862 | 35’157 | 37’200 |
| Summe Aktiva | 36’593 | 39’207 | 45’058 | 47’490 | 50’742 |
Bilanz (in Mio. USD) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 41’588 | 42’125 | 45’623 | 44’598 | 49’253 |
| Summe Eigenkapital | -4’995 | -2’918 | -565 | 2’892 | 1’489 |
| Summe Passiva | 36’593 | 39’207 | 45’058 | 47’490 | 50’742 |
Adresse
| One Park Plaza, 37203-6527 Nashville | |
| Telefon | +1 (615) 344-9551 |
| URL | http://www.hcahealthcare.com |
Management
|
Andrea B. Smith
Independent Director |
|
Chad Wasserman
Chief Information Officer & Senior Vice President |
|
Christopher F. Wyatt
Chief Accounting Officer, Senior VP & Controller |
|
Deborah M. Reiner
Senior VP-Marketing & Corporate Affairs |
|
Frank G. Morgan
Vice President-Investor Relations |
|
Hugh F. Johnston
Independent Director |
|
Jeff E. Cohen
Senior Vice President-Government Relations |
|
Jennifer Berres
Chief Human Resource Officer & Senior VP |
|
John M. Franck
Secretary & Vice President-Legal |
|
Jon M. Foster
Chief Operating Officer & Executive Vice President |
|
Joseph A. Sowell
Chief Development Officer & Senior Vice President |
|
Kathleen M. Whalen
Senior VP, Chief Ethics & Compliance Officer |
|
Mary G. Crofton
Independent Director |
|
Michael R. McAlevey
Executive VP, Chief Legal & Administrative Officer |
|
Michael S. Cuffe
Chief Clinical Officer & Vice President |
|
Michael Schlosser
Senior VP-Care Transformation & Innovation |
|
Michael W. Michelson
Independent Director |
|
Mike A. Marks
Chief Financial Officer & Executive Vice President |
|
Nancy-Ann M. DeParle
Independent Director |
|
Phillip G. Billington
Senior Vice President-Internal Audit Services |
|
Pranav C. Mehta
Chief Medical Officer-American & Atlantic Groups |
|
Randy Fagin
Chief Medical Officer-National Group |
|
Robert J. Dennis
Independent Director |
|
Sammie Mosier
Chief Nurse Officer & Senior Vice President |
|
Samuel N. Hazen
President, Chief Executive Officer & Director |
|
Seenu Reddy
Surgical Director |
|
Sherri Neal
Chief Diversity Officer |
|
Thomas Fearn Frist
Chairman |
|
Wayne Joseph Riley
Independent Director |
|
William Robert Frist
Director |